III. Current concepts in primary central nervous lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|33|S1|25-28

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.33, Iss.S1, 2015-06, pp. : 25-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Primary Central Nervous System Lymphoma

By El Kamar Francois G.   Abrey Lauren E.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 4, 2004-07 ,pp. : 341-349

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Natalizumab: First report of primary central nervous system lymphoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1273, 2009-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Central Nervous System Involvement in Pediatric Rheumatic Diseases: Current Concepts in Treatment

By  

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1295-1301

Bentham Science Publishers

Access to resources Recommend Favorite

Current Approaches for Drug Delivery to Central Nervous System

By  

Current Drug Delivery, Vol. 7, Iss. 5, 2010-12 ,pp. : 389-397

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Central Nervous System Involvement Associated with Primary Sjogren's Syndrome

By  

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1270-1273

Bentham Science Publishers

Access to resources Recommend Favorite